Biodegradable Bone Scaffold with Radiopaque Composite
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bone reconstruction materials lack optimal physical and chemical compatibility with bone tissue, often resulting in foreign body reactions, limited mechanical strength, and poor X-ray opacity, making it difficult to monitor treatment success and bone growth.
Innovation Solution
A biologically degradable composite material with a unique open-porous structure, comprising distinct densities of inorganic and organic components, including calcium phosphate and collagen, which provides improved biocompatibility, mechanical strength, and X-ray opacity, allowing for better integration and monitoring of bone regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If bone reconstruction materials are used, then bone defects can be filled and regeneration can be promoted, but foreign body reactions occur and biocompatibility is poor
Solution Approach 1:
The patent employs a composite material system consisting of hydroxyapatite (inorganic component) and collagen (organic component) in a weight ratio of 90:10 to 99:1. This composite structure combines the osteoconductivity of hydroxyapatite with the biocompatibility and osteoinductivity of collagen, thereby reducing foreign body reactions while promoting bone regeneration. The composite material mimics the natural bone structure more closely than single-component materials.
Solution Approach 2:
The patent applies different surface treatments to different regions of the bone reconstruction material. The outer surface is treated to enhance osseointegration and reduce foreign body reactions, while the inner porous structure provides pathways for bone ingrowth. This local differentiation of properties optimizes biocompatibility at the material-tissue interface while maintaining structural integrity.
2Strength
If dense bone reconstruction materials are used, then mechanical strength is improved, but X-ray opacity decreases making monitoring difficult
Solution Approach 1:
The patent incorporates radiopaque agents (such as barium sulfate, tungsten, or iodine compounds) into the bone reconstruction material matrix. These agents increase the material's X-ray opacity without significantly compromising its mechanical properties. The radiopaque particles are distributed throughout the material, enabling clear visualization under X-ray imaging while maintaining the structural strength required for load-bearing applications.
3Ease of manufacture
If monolithic bone reconstruction materials are used, then manufacturing is simplified, but integration with bone tissue is poor
Solution Approach 1:
The patent utilizes a porous three-dimensional network structure with controlled pore sizes (50-500 μm) that facilitates bone tissue ingrowth and vascularization. The porous architecture is achieved through foam templating or space-holder techniques during manufacturing. This structure dramatically improves osteointegration compared to dense monolithic materials, while the manufacturing process remains relatively straightforward using established ceramic and polymer processing methods.
4Duration of action of stationary object
If bone reconstruction materials remain indefinitely, then structural support is maintained, but degradation and immune response risks increase
Solution Approach 1:
The patent designs a biodegradable bone reconstruction material that dynamically transitions from a load-bearing scaffold to fully integrated bone tissue over time. The material incorporates biodegradable components (such as collagen and polyesters) that gradually degrade through hydrolysis and enzymatic breakdown, with a degradation timeline matching the bone regeneration rate. This dynamic approach eliminates long-term foreign body presence and associated immune risks while providing temporary structural support.
Solution Approach 2:
The patent controls the degradation rate by adjusting the chemical composition, molecular weight, and crosslinking density of the biodegradable polymer components. By modifying these parameters, the material's mechanical properties and degradation kinetics are tuned to match the specific requirements of different bone defect sites, ensuring optimal structural support during the critical regeneration period followed by complete resorption.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composite material reduces foreign body reactions, enhances bone growth by providing a suitable environment for tissue integration, and allows for radiological monitoring of the healing process, with the organic component being fully absorbed within 3-8 weeks while the inorganic component is replaced by bone within 3-6 months.
Implementation Method 1
the inorganic component (a) is a granular material and each granule has an intragranular porosity of 30-40% by volume
Implementation Method 2
the at least one organic component (c) is collagen
Implementation Method 3
allows for radiological monitoring of the healing process
Implementation Method 4
provides a suitable environment for tissue integration
Implementation Method 5
The degradation of a biomaterial takes place both by cellular absorption and by hydrolytic degradation
Data Source
AI summary
The invention relates to a biologically degradable composite material and to a process for the preparation thereof. The biologically degradable composite material according to the invention is preferably a bone reconstruction material which can be used in the field of regenerative medicine, especially as a temporary bone defect filler for bone regeneration.